IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 78 filers reported holding IDERA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 2.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $45,000 | -99.1% | 34,234 | -98.7% | 0.00% | -100.0% |
| Q1 2018 | $5,034,000 | -27.0% | 2,735,802 | -16.3% | 0.00% | 0.0% |
| Q4 2017 | $6,896,000 | -8.4% | 3,268,108 | -2.7% | 0.00% | -50.0% |
| Q3 2017 | $7,526,000 | +89.3% | 3,359,875 | +45.4% | 0.00% | +100.0% |
| Q2 2017 | $3,975,000 | -45.6% | 2,311,400 | -21.9% | 0.00% | -50.0% |
| Q1 2017 | $7,310,000 | +64.3% | 2,959,510 | -0.2% | 0.00% | +100.0% |
| Q4 2016 | $4,450,000 | -42.2% | 2,966,625 | -1.3% | 0.00% | -50.0% |
| Q3 2016 | $7,696,000 | +56.5% | 3,006,375 | -6.5% | 0.00% | +100.0% |
| Q2 2016 | $4,919,000 | -25.8% | 3,214,950 | -4.0% | 0.00% | -50.0% |
| Q1 2016 | $6,632,000 | -32.1% | 3,349,700 | +5.9% | 0.00% | 0.0% |
| Q4 2015 | $9,771,000 | +46.0% | 3,162,075 | +58.3% | 0.00% | 0.0% |
| Q3 2015 | $6,693,000 | +58.0% | 1,998,050 | +75.0% | 0.00% | +100.0% |
| Q2 2015 | $4,235,000 | +4941.7% | 1,141,550 | +4928.9% | 0.00% | – |
| Q1 2015 | $84,000 | -67.9% | 22,700 | -64.7% | 0.00% | – |
| Q1 2014 | $262,000 | – | 64,246 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|